US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stage

0.3754

+0.0000

Volume:- -

Turnover:- -

Market Cap:10.85M

PE:-0.11

High:0.3754

Open:0.3754

Low:0.3754

Close:0.3754

Loading ...

Overview Company News Filings

Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery

Scott Black's Strategic Moves: MGP Ingredients Inc. Takes Center Stage in Q3 2024 Portfolio

Diamond Hill Capital's Strategic Moves: Lululemon Athletica Inc. Takes Center Stage

Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

Kendrick Lamar Takes the Halftime Show Stage

Firebird signs MoU to propel Chinese manganese plant into ‘Stage One’ production

The Market Herald

Safe Superintelligence (SSI) Aims for $20 Billion Valuation. Is This the Future of AI?

Reynhard Sinaga's Repatriation Plan from UK in Early Stage, Says Minister Yusril

Lanthanein Resources Completes First Stage of Diamond Drilling at Western Australia Project

MT Newswires Live

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Asian Morning Briefing: U.S. Stocks Rise as Earnings, Economy Retake Center Stage

Azvalor Internacional FI's Strategic Moves: Noble Corp PLC Takes Center Stage with 10. ...

Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage

MT Newswires Live

Innovative Eyewear Takes Center Stage at MIDO 2025 with Reebok Smart Eyewear Line Launch

U.S. Stocks Stage Small Recovery -- WSJ

Mineralys Completes Enrollment in Mid-Stage Hypertension Trial

MT Newswires Live

Bestinfond's Strategic Moves: Smurfit WestRock PLC Takes Center Stage

Tariffs Shouldn't Hurt F&P Healthcare's Valuation Materially at This Stage -- Market Talk

Ingersoll Rand Acquires SSI Aeration

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SSI/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","market":"US","secType":"STK","nameCN":"Stage","latestPrice":0.3754,"timestamp":1588968000000,"preClose":0.3754,"halted":3,"volume":0,"delay":0,"floatShares":20307519,"shares":28911336,"eps":-3.332056,"marketStatus":"Halted","change":0,"latestTime":"05-08 16:00:00 EDT","open":0.3754,"high":0.3754,"low":0.3754,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.332056,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":998884800000,"exchange":"NYSE","adjPreClose":0.3754,"dividendRate":0.133191,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","floatShares":20307519,"roa":"-3.54%","roe":"-44.60%","lyrEps":-3.1264,"shares":28911336,"dividePrice":0.05,"high":0.3754,"amplitude":0,"preClose":0.3754,"low":0.3754,"week52Low":0.27,"pbRate":"0.07","week52High":9.5,"institutionHeld":0.5253,"latestPrice":0.3754,"eps":-3.332056,"divideRate":0.133191,"volume":0,"delay":0,"ttmEps":-3.332056,"open":0.3754,"prevYearClose":8.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSI\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510938383","title":"Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=2510938383","media":"CNW Group","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510938383?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275200,"startTime":"0","endTime":"0","summary":"Approval is based on the Phase 3 KEYNOTE-671 Trial. \"While we have made significant advancements for patients with advanced lung cancer, it remains the leading cause of cancer-related deaths in Canada. This underscores the importance of addressing lung cancer cases in earlier stages, to help improve patient outcomes,\" stated Dr. JonathanSpicer, thoracic surgeon and scientist at the McGill University Health Centre , Scientist in the Cancer Research Program at The Institute, Professor of Surgery at McGill University, and Medical Director of the McGill Thoracic Oncology Network. \"This recent approval adds another therapeutic option for patients with operable non-small cell lung cancer.\". \"Today, we've made a significant step forward with the approval of the first anti-PD-1 therapy in Canada for the perioperative treatment of resectable non-small cell lung cancer. This approval highlights our commitment to expanding treatment options for lung cancer patients,\" expressed André Galarneau, Ph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/health-canada-approves-mercks-keytruda-120000682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0861579265.USD","IE00B4R5TH58.HKD","LU0265550359.USD","LU1989771016.USD","OS","SG9999014567.USD","LU1934455863.HKD","SG9999002224.SGD","LU2461242641.AUD","IE00BJJMRZ35.SGD","LU1989772840.SGD","BK4588","MRK","IE00BBT3K403.USD","LU0965509283.SGD","SG9999014575.USD","LU0320765489.SGD","BK4550","SG9999015341.SGD","SSI","LU1066051498.USD","LU2106854487.HKD","SG9999001176.USD","LU2089984988.USD","LU0985320562.USD","LU1699723380.USD","LU1983299246.USD","LU0965509010.AUD","SG9999013999.USD","LU1093756168.USD","SG9999014559.SGD","BK4007","LU0006306889.USD","LU1037948541.HKD","LU0058720904.USD","LU0211331839.USD","IE000M9KFDE8.USD","LU1116320737.USD","LU1037948897.HKD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1989772923.USD","LU0070302665.USD","SG9999002232.USD","LU2361045086.USD","LU2023250843.SGD","LU1917777945.USD","IE00BLSP4239.USD","LU1066051225.USD"],"gpt_icon":1},{"id":"2510833814","title":"Scott Black's Strategic Moves: MGP Ingredients Inc. Takes Center Stage in Q3 2024 Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2510833814","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510833814?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:20","pubTimestamp":1739226059,"startTime":"0","endTime":"0","summary":"Delphi Management's Founder Emphasizes Value Investing Scott Black (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2024, providing insights into his investment moves dur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2690028/scott-blacks-strategic-moves-mgp-ingredients-inc-takes-center-stage-in-q3-2024-portfolio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["LU1571399168.USD","LU1935042488.USD","MACW.SI","SG9999015358.SGD","LU1506573853.SGD","LU1316542783.SGD","LU2360032135.SGD","LU1917777945.USD","LU2505996509.AUD","IE00B19Z8X17.USD","IE00BN29S564.USD","BK4576","BRK.B","LU2237443622.USD","LU2471134952.CNY","IE00BLSP4452.SGD","LU0788109477.HKD","IE0004445239.USD","LU2456880835.USD","LU0719512351.SGD","LU2083900584.USD","LU0979878070.USD","LU1989772923.USD","LU0943347566.SGD","LU0323591593.USD","IE00B19Z8W00.USD","LU0251132253.USD","LU0661504455.SGD","LU2552382058.USD","LU0314104364.USD","BK4579","LU2247934214.USD","SSI","LU0234572021.USD","LU1301847155.USD","LU0109392836.USD","LU0345769631.USD","LU0784384876.USD","LU0642271901.SGD","MGP","IE00B19Z9505.USD","LU0868494617.USD","BK4550","LU0096362180.USD","LU0511384066.AUD","SG9999014567.USD","MGPI","LU0354030438.USD","AAPL","LU1066051811.HKD"],"gpt_icon":1},{"id":"2510589548","title":"Diamond Hill Capital's Strategic Moves: Lululemon Athletica Inc. Takes Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2510589548","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510589548?lang=en_us&edition=fundamental","pubTime":"2025-02-11 02:03","pubTimestamp":1739210623,"startTime":"0","endTime":"0","summary":"Insightful Analysis of Diamond Hill Capital 's Latest 13F Filing. Diamond Hill Capital  recently submitted its 13F filing for the fourth quarter of 2024, shedding light on its strategic investment decisions during this period. Established in 2000, Diamond Hill Capital  Management, Inc. is a registered investment adviser based in Columbus, Ohio. The firm is independent and publicly owned, listed on the NASDAQ under the ticker symbol DHIL, and is part of the Russell 2000 Index. Diamond Hill manages a diverse range of equity strategies, including traditional and alternative options, available through separately managed accounts, mutual funds, and private investment funds. The firm's client base spans institutions, financial intermediaries, and individuals. Diamond Hill's investment approach is primarily bottom-up, focusing on fundamental analysis of a company's profitability, market position, and other key factors, while also considering industry dynamics through top-down analysis.Diamond","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/diamond-hill-capitals-strategic-moves-180343452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0882574055.USD","LU0130103400.USD","LU0985320562.USD","NVIW.SI","LU0053666078.USD","COP","TQQQ","BAC","USAW.SI","ABT","BK4566","SYK","QID","TFX","IE00BGHQF524.EUR","LU0238689110.USD","QLD","IE00BK4W5L77.USD","LU0310800965.SGD","USJW.SI","BRK.A","HIL","LULU","LU2108987350.USD","LU0417517546.SGD","LU0971096721.USD",".IXIC","LU0630314457.HKD","IE0002270589.USD","PEP","PH","MNQmain","CL","FANG","ALL","LU0256863902.USD","BRK.B","NQmain","PSQ","BK4570","LU0957791311.USD","LU0823411888.USD","AIG","BK4504","TSYW.SI","DHIL","SQQQ","SSI","LU0072461881.USD"],"gpt_icon":1},{"id":"2510857623","title":"Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2510857623","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510857623?lang=en_us&edition=fundamental","pubTime":"2025-02-10 21:32","pubTimestamp":1739194324,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics, Inc.  stock is trading lower on Monday.On Friday, during after-hours trading, Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis , a chronic lung disease that causes scarring and stiffening of the lung tissue.Patients currently enrolled in BEACON-IPF will remain in the trial.The move follows a prespecified data review and recommendations by the trial’s independent Data Safety Monitoring Board.In May 2024, On Tuesday,Pliant Therapeutics announced topline data from a Phase 2a PET Imaging trial ofbexotegrast evaluating change in total collagen levels in the lungs of patients with idiopathic pulmonary fibrosis  characterized by excessive collagendeposition in the lung.Last February, Pliant Therapeutics released 12-week interim data from the 320 mg dose group of INTEGRIS-PSC Phase 2a trial of bexotegrast in patients with primary sclerosing ch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pliant-therapeutics-pauses-lead-product-133204055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSC","PET","LENZ","PLRX","BK4192","BK4007","SSI","BK4139"],"gpt_icon":0},{"id":"2510854639","title":"Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2510854639","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510854639?lang=en_us&edition=fundamental","pubTime":"2025-02-10 21:00","pubTimestamp":1739192400,"startTime":"0","endTime":"0","summary":"Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest. These findings, led by Ocean Biomedical’s Scientific Co-founder Dr. Jack A. Elias in collaboration with researchers at Yale University and Brown University, were published in Translational Oncology and mark the first description of the role of chitinase 3-like-1  in EGFR-mutant cancers. The research underscores the ability of Ocean Biomedical’s novel antibody to suppress CHi3L1 activity, leading to significant tumor reduction and, crucially, the reversal of drug resistance in preclinical models.Ocean has also developed bispecific antibodies that combine its anti-CHI3L1 antibody and anti-PD-1 or anti-CTLA4. Studies with these bispecific antibodies have highlighted their impressive efficacy in suppressing tumor growth and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocean-biomedical-announces-breakthrough-findings-130000492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OCEA","OCEAW","SSI","BK4139"],"gpt_icon":0},{"id":"2510077633","title":"Kendrick Lamar Takes the Halftime Show Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2510077633","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510077633?lang=en_us&edition=fundamental","pubTime":"2025-02-10 09:32","pubTimestamp":1739151120,"startTime":"0","endTime":"0","summary":"Kendrick Lamar spent months trading diss tracks with rival rapper Drake. So ahead of the Super Bowl, fans wondered: Would he play his biggest hit from the feud, the Grammy-winning song \"Not Like Us,\" on the field at halftime?Samuel L. Jackson introduced Lamar dressed as Uncle Sam in front of a giant Tic-Tac-Toe board. The rapper opened his set with \"GNX\" and \"Squabble Up,\" perched on a Buick GNX as dancers dressed in red, white and blue hopped out.\"The revolution about to be televised,\" Lamar said.This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL .","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI"],"gpt_icon":0},{"id":"2510071004","title":"Firebird signs MoU to propel Chinese manganese plant into ‘Stage One’ production","url":"https://stock-news.laohu8.com/highlight/detail?id=2510071004","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510071004?lang=en_us&edition=fundamental","pubTime":"2025-02-10 08:04","pubTimestamp":1739145840,"startTime":"0","endTime":"0","summary":"Firebird Metals Ltd  has taken a decisive step in its development of manganese sulphate  and manganese tetra-oxide  plant in China.The company has this week signed a non-binding memorandum of understanding  with French multinational Eramet for manganese ore.Eramet will supply 80,000 tonnes of manganese annually – and 20,000 tonnes quarterly – for Stage One of Firebird’s proposed operations at the plant. This is well beyond the required 66,000tpa set out in Firebird’s feasibility study, with the additional tonnage to act as a strategic buffer to mitigate potential disruptions.The MoU comes after successful testing of a 200-kilogram sample of Eramet’s ore-producing battery-grade MnSO4  andmanganese tetraoxide  – at Firebird’s Jinshi R&D centre.“I am very pleased to announce that Firebird has entered into a MoU agreement with Eramet, a world-renowned supplier of manganese ore and a truly high-calibre partner,” Firebird managing director Peter Allen said.The material provided in this artic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/firebird-signs-mou-to-propel-chinese-manganese-plant-into-stage-one-production-2025-02-10/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["FRB.AU","SSI","BK7129"],"gpt_icon":0},{"id":"2510049480","title":"Safe Superintelligence (SSI) Aims for $20 Billion Valuation. Is This the Future of AI?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510049480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510049480?lang=en_us&edition=fundamental","pubTime":"2025-02-09 21:18","pubTimestamp":1739107114,"startTime":"0","endTime":"0","summary":"Ilya Sutskever, former chief scientist at OpenAI, is on a mission to create a new vision and future for AI that surpasses human intelligence and al...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/safe-superintelligence-ssi-aims-for-20-billion-valuation-is-this-the-future-of-ai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/safe-superintelligence-ssi-aims-for-20-billion-valuation-is-this-the-future-of-ai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2509671628","title":"Reynhard Sinaga's Repatriation Plan from UK in Early Stage, Says Minister Yusril","url":"https://stock-news.laohu8.com/highlight/detail?id=2509671628","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509671628?lang=en_us&edition=fundamental","pubTime":"2025-02-07 15:26","pubTimestamp":1738913181,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -The Coordinating Minister of Law, Human Rights, Immigration, and Corrections, Yusril Ihza Mahendra, said his side is reviewing the plan to repatriate Reynhard Sinaga, the sexual offender sentenced to life in UK prison. Yusril mentioned the discussion also involved Reynhard’s family.“We’re reviewing the matter and working alongside the Ministry of Foreign Affairs,” he said in a video statement received by Tempo, quoted on Friday, February 7, 2025.The former chief of the Crescent Star Party stated that the repatriation plan for Reynhard stemmed from his family’s request, but the minister can’t confirm whether the request will be granted. The talks to repatriate Reynhard are in early stages, and a study on UK’s applicable laws must be conducted.","market":"nz","thumbnail":"https://statik.tempo.co/data/2025/02/04/id_1374831/1374831_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/02/04/id_1374831/1374831_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1972726/reynhard-sinagas-repatriation-plan-from-uk-in-early-stage-says-minister-yusril","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2509751214","title":"Lanthanein Resources Completes First Stage of Diamond Drilling at Western Australia Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2509751214","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509751214?lang=en_us&edition=fundamental","pubTime":"2025-02-07 11:31","pubTimestamp":1738899061,"startTime":"0","endTime":"0","summary":"Lanthanein Resources  completed the initial stage of diamond drilling at its Lady Grey project in Western Australia, according to a Friday filing with the Australian bourse.The drilling is testing a modeled conductor plate under moving loop electromagnetic  survey line 6, with assay results expected in this quarter, the filing said.Additionally, the company received approval from the Department of Energy, Mines, Industry Regulation and Safety for the program of work for drilling the MLEM conductor plate under line 1, per the filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","XJO.AU","LNR.AU","WRN","XAO.AU","SSI","BK4168","XKO.AU"],"gpt_icon":0},{"id":"2509781045","title":"Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2509781045","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509781045?lang=en_us&edition=fundamental","pubTime":"2025-02-07 05:15","pubTimestamp":1738876500,"startTime":"0","endTime":"0","summary":"Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first half of 2026; Topline data from Phase 2b LUMUS trial in systemic lupus erythematosus on track for readout in 2026. Evaluation underway of development plan for ACELYRIN’s lonigutamab to confirm differentiation in a capital efficient manner. Alumis and ACELYRIN stockholders to own ~55% and ~45%, respectively, of combined company on a fully diluted basis. Bruce Cozadd, Chair of the ACELYRIN Board of Directors and member of the Board Transaction Committee, said, “This merger represents the culmination of a thorough strategic review process by our Board and management team to determine the best and most value-maximizing path forward for ACELYRIN. We are confident that Alumis is the right partner to optimize the development of lonigutamab and together deliver long-term stockholder value.”“We are pleased to join with Alumis and further advance our mission of develop","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alumis-acelyrin-merge-creating-stage-211500228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALMS","BK4007","SSI","SLRN"],"gpt_icon":0},{"id":"2509252916","title":"Asian Morning Briefing: U.S. Stocks Rise as Earnings, Economy Retake Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2509252916","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509252916?lang=en_us&edition=fundamental","pubTime":"2025-02-06 05:46","pubTimestamp":1738791960,"startTime":"0","endTime":"0","summary":"U.S. stocks closed higher as indicators pointed to a cooling economy that could allow the Fed to cut interest rates down the road. Treasury yields fell as relatively soft economic indicators retook center stage. Oil prices settled at their lowest levels of the year after a bigger-than-expected increase in U.S. inventories. Gold closed at a new record high and the dollar weakened.After trade-war fears ballooned early this week, an old reliable-earnings season-retook center stage in markets.Although the 10% U.S. tariff has already \"prompted tit-for-tat responses from China, markets are all too aware that trade tensions between the world's two largest economies have room to escalate further,\" said Han Tan, chief market analyst at Exinity. \"A significant escalation and broadening of a trade war is set to darken the global economic outlook and could lead to oil demand destruction, potentially offsetting further sanctions on Iranian supplies.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI"],"gpt_icon":0},{"id":"2509023194","title":"Azvalor Internacional FI's Strategic Moves: Noble Corp PLC Takes Center Stage with 10. ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2509023194","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509023194?lang=en_us&edition=fundamental","pubTime":"2025-02-06 01:01","pubTimestamp":1738774875,"startTime":"0","endTime":"0","summary":"Exploring Azvalor Internacional FI 's Investment Strategy and Recent Portfolio Adjustments. GuruFocus has detected 4 Warning Signs with NE.Azvalor Internacional FI  recently submitted its report for the fourth quarter of 2024, shedding light on its strategic investment decisions during this period. This fund is dedicated to investing in undervalued equity assets across global markets, catering to investors with a long-term investment horizon. Adhering to the Value Investment philosophy, Azvalor Internacional FI  focuses on acquiring companies at prices below their intrinsic value. The portfolio predominantly consists of European companies listed on secondary markets, selected individually without bias towards company size, sector, or country.The most significant addition was Noble Corp PLC , with 4,511,080 shares, accounting for 10.5% of the portfolio and a total value of $137.169 million.Arch Resources Inc : Azvalor Internacional FI  sold all 475,257 shares, resulting in a -5.62% impa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azvalor-internacional-fis-strategic-moves-170115114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1169589451.USD","LU0055631609.USD","NE","NOV","LU0068578508.USD","BK4588","LU0965508806.USD","LU0477156797.USD","LU1223082196.USD","SSI","BK4227","BK4570","LU0368265418.SGD","LU0075056555.USD","LU0130102774.USD","LU0289960550.SGD","LU1934455277.USD","LU0368265764.SGD","LU0289739343.SGD","LU0345770993.USD","LU0965509010.AUD","IE00B19Z3581.USD","LU2237438978.USD","FI","SLB","LU0175139822.USD","LU1923622291.USD","LU0130517989.USD","IE00B7SZLL34.SGD","CNQ","LU0724618789.USD","LU0861579265.USD","LU2125909759.SGD","ARCH","LU0061475181.USD","LU0069063385.USD","LU0320765489.SGD","LU2108987350.USD","LU0300736062.USD","SG9999004303.SGD","LU0345780521.USD","LU0208291251.USD","LU1037948897.HKD","LU1861217088.USD","LU0498741890.SGD","GOLD","LU0648000940.SGD","LU1201861249.SGD","LU0234570918.USD","LU1023059493.AUD"],"gpt_icon":0},{"id":"2509280429","title":"Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280429","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509280429?lang=en_us&edition=fundamental","pubTime":"2025-02-05 23:22","pubTimestamp":1738768973,"startTime":"0","endTime":"0","summary":"Vaxcyte  said Wednesday its ongoing phase 2 study assessing VAX-31 for the prevention of invasive pneumococcal disease in infants is advancing to its second and final stage.The company said participants who received VAX-31 in the first stage will continue the standard dosing regimen as part of the second stage.Vaxcyte said it expects to release topline data from the study's primary three-dose immunization series in the middle of next year, followed by topline data from the booster dose about nine months later.In infants, the VAX-31 was designed to cover about 94% of invasive pneumococcal disease and roughly 93% of acute otitis media caused by streptococcus pneumoniae in children under five years old in the United States.Shares of Vaxcyte were up nearly 3% in recent trading.Price: 88.88, Change: +2.37, Percent Change: +2.73","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PCVX","IE0009354923.USD","LU0053671581.USD","SSI","BK4139"],"gpt_icon":0},{"id":"2509286772","title":"Innovative Eyewear Takes Center Stage at MIDO 2025 with Reebok Smart Eyewear Line Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2509286772","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509286772?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:30","pubTimestamp":1738762200,"startTime":"0","endTime":"0","summary":"MIAMI, Feb. 5, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. , the developer of ChatGPT-enabled smart eyewear under the Lucyd, Nautica, Eddie Bauer and Reebok brands, is pleased to announce its participation in MIDO 2025, the world's leading eyewear exhibition, from February 8th to 10th in Milan, Italy. This event is an invitation for all to witness the worldwide debut of our Reebok Smart Eyewear line, crafted for active and connected lifestyles. The event marks a significant milestone for the company as it unveils its much-anticipated Reebok Powered by Lucyd Smart Eyewear line to a global audience.Experience the Future of EyewearVisitors to theLucyd booth  can get a first look at the new Reebok Smart Eyewear line, designed for active lifestyles. The collection integrates wearable audio technology with lightweight, sport-focused frames, offering hands-free connectivity and open-ear audio. Featuring an upgraded audio system, the eyewear delivers enhanced clarity and deeper bass, all at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/innovative-eyewear-takes-center-stage-133000585.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innovative-eyewear-takes-center-stage-133000585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LUCYW","SMTEF","SSI","BK4198","LUCY","BK4157"],"gpt_icon":0},{"id":"2509346264","title":"U.S. Stocks Stage Small Recovery -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2509346264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509346264?lang=en_us&edition=fundamental","pubTime":"2025-02-05 01:40","pubTimestamp":1738690800,"startTime":"0","endTime":"0","summary":"U.S. stocks staged a small recovery Tuesday, despite China's retaliation against the new U.S. tariffs.The moves were milder than Monday's big swings, and some signs of investor anxiety remained.Stocks indexes largely rose. The Dow industrials was little changed, while the S&P 500 rose 0.6%. The tech-heavy Nasdaq Composite led gains, up over 1.2%.The Cboe Volatility Index, or VIX, fell below 18, after surging Monday. The \"fear gauge\" is higher than the average of about 16 over the past year, but far from panic territory.Yields on benchmark Treasury notes were little changed. The 10-year yield traded around 4.54%, compared with 4.542% Monday.The WSJ Dollar Index edged down. The Canadian dollar advanced against the dollar, as did the Chinese yuan, while the euro and British pound slipped.Oil prices were volatile. U.S. crude futures slid below $71 a barrel, before rebounding back above $72.Write to Caitlin McCabe at caitlin.mccabe@wsj.com and Krystal Hur at krystal.hur@wsj.com. This item i","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI"],"gpt_icon":0},{"id":"2509466205","title":"Mineralys Completes Enrollment in Mid-Stage Hypertension Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466205","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509466205?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:20","pubTimestamp":1738686003,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics  said Tuesday it has completed enrollment in the phase 2 trial of lorundrostat for the treatment of hypertension in subjects with chronic kidney disease and albuminuria.The clinical-stage biopharmaceutical company said it continues to expect topline data from the trial in Q2 of 2025.Price: 9.92, Change: -0.01, Percent Change: -0.10","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSI","MLYS","BK4139"],"gpt_icon":0},{"id":"2508346587","title":"Bestinfond's Strategic Moves: Smurfit WestRock PLC Takes Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2508346587","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508346587?lang=en_us&edition=fundamental","pubTime":"2025-02-04 23:02","pubTimestamp":1738681346,"startTime":"0","endTime":"0","summary":"Exploring Bestinfond (Trades, Portfolio)'s Fourth Quarter 2024 Investment Decisions Bestinfond (Trades, Portfolio) recently submitted its report for the fourth quarter of 2024, offering a glimpse into","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2679988/bestinfonds-strategic-moves-smurfit-westrock-plc-takes-center-stage","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["LU1803068623.USD","BK4534","LU2360108059.USD","BRK.A","IE00BWXC8680.SGD","LU0251131958.USD","BK4533","BRK.B","LU2242646821.SGD","IE00B1BXHZ80.USD","LU0417517546.SGD","BK4588","IE0034235303.USD","LU2092937221.SGD","LU2380233275.USD","LU0612318385.USD","LU0980610538.SGD","LU0251142724.SGD","BK4585","LU0971096721.USD","IE00BK4W5L77.USD","LU0648001328.SGD","LU1863844665.USD","LU0130102774.USD","SSI","LU1571399168.USD","LU1989763427.SGD","LU1920062954.HKD","IE00B3S45H60.SGD","LU1863844749.USD","LU0157215616.USD","LU1074936037.SGD","LU0048578792.EUR","LU2242646235.USD","LU0742534661.SGD","LU0997586606.USD","LU0234570918.USD","IE000M9KFDE8.USD","LU1201861249.SGD","LU1363072403.SGD","LU2041044095.USD","SW","IE00B1XK9C88.USD","LU0640476718.USD","LU1989763690.USD","LU1430597077.USD","LU0550127509.SGD","LU0471298777.SGD","LU2298321311.HKD","LU1914381329.SGD"],"gpt_icon":1},{"id":"2508717257","title":"Tariffs Shouldn't Hurt F&P Healthcare's Valuation Materially at This Stage -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2508717257","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508717257?lang=en_us&edition=fundamental","pubTime":"2025-02-04 07:37","pubTimestamp":1738625820,"startTime":"0","endTime":"0","summary":"2337 GMT - Breathing device maker Fisher & Paykel Healthcare's shares rise 2.5% to claw back some of Monday's steep fall, helped by President Trump agreeing to a monthlong delay to a levy on imports from Mexico. In a note, analyst Matt Montgomerie thinks the tariff threat shouldn't have a material impact on F&P Healthcare's valuation at this stage because the tariffs may ultimately be reversed or revised. Also, F&P Healthcare can shift production back to New Zealand and use Mexico as a hub for other markets. \"The latter would take time to implement, but over the long term there shouldn't be a material change in F&P Healthcare's gross margin outlook,\" Forsyth Barr says. \"This is confirmed by F&P Healthcare still expecting to reach its 65% target, albeit two to three years later than its original FY 2027/FY 2028 expectations.\" ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI","BK4137","HCSG"],"gpt_icon":0},{"id":"2508179889","title":"Ingersoll Rand Acquires SSI Aeration","url":"https://stock-news.laohu8.com/highlight/detail?id=2508179889","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508179889?lang=en_us&edition=fundamental","pubTime":"2025-02-04 06:18","pubTimestamp":1738621080,"startTime":"0","endTime":"0","summary":"Ingersoll Rand on Monday said it acquired SSI Aeration, which designs and makes wastewater treatment plant equipment.The acquisition will enable Ingersoll Rand the opportunity to expand its capabilities in wastewater treatment, and to provide more comprehensive wastewater treatment solutions, the company said.SSI has about $30 million in annual revenue and manufacturing facilities in the U.S., South Korea, and India.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","SSI","LU0124384867.USD","LU0417517546.SGD","BK4585","BK4161","LU1978683503.SGD","BK4588","SG9999001440.SGD","IR","LU0256863902.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-21","symbol":"SSI","fiscalQuarterEnding":"2019/10","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1574312400000,"reportTimeType":"pre","actualEps":-0.15},{"date":"2019-08-22","symbol":"SSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/07","expectedEps":null,"defaultRemindTime":1566460800000,"name":null,"time":"Pre-Market","dateTimestamp":1566446400000,"actualEps":-0.6},{"market":"US","date":"2019-05-23","symbol":"SSI","fiscalQuarterEnding":"2019/04","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1558584000000,"reportTimeType":"pre","actualEps":-1.67},{"market":"US","date":"2019-03-07","symbol":"SSI","fiscalQuarterEnding":"2019/01","expectedEps":0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2018-12-03","symbol":"SSI","amount":0.05,"name":"Stage Stores Inc","currency":"USD","type":"dividend","dateTimestamp":1543813200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSI\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-08-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-11-27","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2018-03-05","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSI\",market:\"US\",delay:false,,,undefined,":{}}}